Galaxa Pharma a/s
CVR 41183144 · Public limited company (A/S) · Active · Very high risk
Galaxa Pharma a/s is a Public limited company (A/S), founded on , based in København Ø. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 12.9% over the next 12 months, which is 9.2 times the average for Danish companies. 6 annual reports have been published, of which 3 more than six months after the end of the financial year. The latest annual report (30 Sep 2025) shows equity of DKK -210k and a net result of DKK -461k.
Bankruptcy risk for Galaxa Pharma a/s
9.2 × the average (1.41%) · higher risk than 98% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 41183144
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (6 years)
- Address
- Indiakaj 10, 2.
2100 København Ø - Municipality
- København
- Industry
- Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 1.0m
- Auditor
- CHRISTENSEN KJÆRULFF STATSAUTORISERET REVISIONSAKTIESELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 3 of 6 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -14.9% |
| Current ratio | 87% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 7 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -399k | DKK -898k | DKK -2.0m |
| Net profit | DKK -461k | DKK -820k | DKK -1.7m |
| Equity | DKK -210k | DKK 252k | DKK 572k |
| Total assets | DKK 1.4m | DKK 1.6m | DKK 2.6m |
| Cash | DKK 1,009 | DKK 14k | – |
| Short-term debt | DKK 1.6m | DKK 1.3m | – |
| Avg. employees | 1 | 1 | – |
Latest annual report: Reporting class B · auditor's statement: Erklæring om udvidet gennemgang · Christensen Kjærulff, Statsautoriseret Revisionsaktieselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Oct 2024 – 30 Sep 2025 | 192 | Late | |
| 1 Oct 2023 – 30 Sep 2024 | 186 | Late | |
| 1 Oct 2022 – 30 Sep 2023 | 193 | Late | |
| 1 Oct 2021 – 30 Sep 2022 | 179 | ||
| 1 Oct 2020 – 30 Sep 2021 | 77 | ||
| 7 Feb 2020 – 30 Sep 2020 | 152 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| Board | Gitte Henriksen | Current | |
| Board | Lone Henriksen | Current | |
| Board | Jens Jørgen Hagelskjær | Current | |
| Board | Gitte Henriksen | ||
| Board | Lone Henriksen | ||
| Board | Simon Tønners | ||
| Board | Jørgen Flemming Ladefoged | ||
| Board | Anders Permin | ||
| Board | Stein Arve Løkstad | ||
| Board | Bo Erik Lennart Unéus | ||
| Board | Jørgen Flemming Ladefoged | ||
| Board | Alexandre Fevre | ||
| Board | Karsten Adelmark | ||
| Board | Ib Madsen | ||
| Board | Flemming Heegaard | ||
| Board | Jesper Herold Halle | ||
| Board | Mads Verner Jørgensen | ||
| Owner (100%) | CS MEDICA a/s | Current | |
| Auditor | CHRISTENSEN KJÆRULFF STATSAUTORISERET REVISIONSAKTIESELSKAB | Current | |
| Founder | CS MEDICA a/s | Current |
Address history (3 moves)
| Indiakaj 10, 2., 2100 København Ø | |
| Fruebjergvej 3, 2100 København Ø | |
| Korskildelund 6, 2670 Greve | |
| c/o Lone Henriksen, Olsbæk Strandvej 5, 2670 Greve |
Former names
| Galaxa Pharma a/s | – now |
| CanNordic A/S | – |
Other companies at the same address
- CITIZEN DANE ApS Bankrupt
- CS MEDICA a/s Active
- CanNordic a/s Active
- EURO SELECT ApS Opløst
- GLOBESEARCH A/S Fusioneret
- GLOBETECH A/S Fusioneret
- WIREFREE SERVICES DENMARK A/S Active
Similar companies in København
- ALFASCAN ApS København K
- LUNDBECK PHARMA A/S Valby
- ASTRAZENECA A/S København V
- Sundvik ApS Vanløse
- DEXCOM DENMARK, ApS København Ø
- Nitrilehandsker.dk ApS Valby
- DePuy Synthes (Denmark) ApS København K
- ELSE NORDICS APS København S
- MSD Animal Health A/S København V
- DentFriends ApS København S
- Sanad Health ApS København N
- Venteus Medical Devices (ROW) ApS København Ø
Questions and answers about Galaxa Pharma a/s
Has Galaxa Pharma a/s gone bankrupt?
No, Galaxa Pharma a/s is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Galaxa Pharma a/s?
Our model estimates a bankruptcy risk of 12.9% over the next 12 months (very high risk), which is 9.2 times the average for Danish companies.
Who is the auditor of Galaxa Pharma a/s?
Galaxa Pharma a/s most recently used CHRISTENSEN KJÆRULFF STATSAUTORISERET REVISIONSAKTIESELSKAB.
When was Galaxa Pharma a/s founded?
Galaxa Pharma a/s was founded on 7 February 2020.
What is the equity of Galaxa Pharma a/s?
Equity was DKK -210k according to the annual report for the period ending 30 September 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.